3차 의료기관에서 전산화의약품사용평가프로그램 설치 전후의 의약품처방 비교
Drug Prescriptions Comparison Before and After Computerized Drug Utilization Review Program Installation in a Tertiary Hospital Setting
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Drug Utilization Review (DUR) is known to play an important role to improve appropriateness of drug prescriptions. This retrospective, observational study was to compare prescription patterns after installation of Computerized DUR Program (Drug Information Framework-Korea™) (Jan-Mar 2008; After) to before DUR program (Jan-Mar 2007:Before). 8 physicians affiliated in the S University Hospital were enrolled in the study and their 3 months' prescription data were analysed for drug prescription trends and DUR conflict events per 7 DUR screening modules (drug-drug interaction, therapeutic duplication, allergy, dosing, disease contra-indication, geriatric contra-indication, pediatric contraindication). Average rate of DUR modules usage in 2008 (After) were 0.72. Average number of prescription drug per patient were reduced from 5.6 (Before) to 3.8 (After), and DUR program seemed to effect positively on physician's prescription related decision process. Overall DUR conflict events occurred by 8 physicians for 3 months were 17,923Before and 20,057 After DUR program, and DUR conflict events per prescription were 2.8 Before and 2.9 After,respectively. Therapeutic duplication (37%), geriatric contra-indication (34%) and dosing (18%) were high ranked DUR conflicts. As the study was not sufficient to show a consistent trend to reduce DUR conflicts After, another study to confirm it's effectiveness would be recommended. This study would be of help to develop awareness of DUR program to healthcare providers.
Abstract
Drug Utilization Review (DUR) is known to play an important role to improve appropriateness of drug prescriptions. This retrospective, observational study was to compare prescription patterns after installation of Computerized DUR Program (Drug Information Framework-Korea™) (Jan-Mar 2008; After) to before DUR program (Jan-Mar 2007:Before). 8 physicians affiliated in the S University Hospital were enrolled in the study and their 3 months' prescription data were analysed for drug prescription trends and DUR conflict events per 7 DUR screening modules (drug-drug interaction, therapeutic duplication, allergy, dosing, disease contra-indication, geriatric contra-indication, pediatric contraindication). Average rate of DUR modules usage in 2008 (After) were 0.72. Average number of prescription drug per patient were reduced from 5.6 (Before) to 3.8 (After), and DUR program seemed to effect positively on physician's prescription related decision process. Overall DUR conflict events occurred by 8 physicians for 3 months were 17,923Before and 20,057 After DUR program, and DUR conflict events per prescription were 2.8 Before and 2.9 After,respectively. Therapeutic duplication (37%), geriatric contra-indication (34%) and dosing (18%) were high ranked DUR conflicts. As the study was not sufficient to show a consistent trend to reduce DUR conflicts After, another study to confirm it's effectiveness would be recommended. This study would be of help to develop awareness of DUR program to healthcare providers.
참고문헌 (19)
- "To err is human: Building a Safer Health System. Washington, DC: National Academy Press; 1999" (1999)[URL]
- Malone DC, "Identification of Serious Drug-Drug Interactions: Results of the Partnership to Prevent Drug-Drug Interactions", J Am Pharm Assoc, 44(2), pp.142~151 (2004)
- Lazarou J, "Incidence of adverse drug reactions in hospitalized patients: a metaanalysis of prospective studies", JAMA, 279, pp.1200~1205 (1998)
- Leape LL, "The nature of adverse events in hospitalized patients", N Engl J Med, 324, pp.377~384 (1991)
- Johnson JA, "Drug-related morbidity and mortality. A cost-of-illness model", Arch Intern Med, 155, pp.1949~1956 (1995)
- Ernst FR, "Drug-related morbidity and mortality: updating the cost-of-illness model", J Am Pharm Assoc, 41, pp.192~199 (2001)
- 김민선, "외래환자 처방전상에 나타난 약물 상호작용 실태 및 병원 조제담당 약사의 인지도 조사", J Kor Hosp Pharm, 16(2), pp.252~258 (1999)
- 전산화 DUR프로그램을 통한 국민건강보험 약제 비심사 효율성 향상 방안에 대한 연구, "신현택", 건강보험심사평가원, ~ (2003)
- 약화사고의 규모파악과 예방대책에 대한 정책연구 보고서, "신현택", ~ (2006)
- 배성미, "각 약물의 Drug Use Evaluation에 의한 적정성 추 구", J Kor Soc Health-Syst Pharm, 18(4), pp.433~439 (2001)
- Alan L, "Ambulatory Drug Utilization Review: Opportunities for Improved Prescription Drug Use", AJMC, 7(1), pp.75~83 (2001)
- "의약품사용평가(DUR) 학술정보집" (2004), 대한약사회
- Soumerai SB, "Computer-Based Drug- Utilization Review-Risk, Benefit, or Boondoggle", N Engl J Med, 332, pp.1641~1645 (1995)
- 김수미, "히스타민-2 수용체 길항제의 약물사용평가를 통한 의약분업 전후의 약제서비스 질 개선 평가 연구", 석사, pp.2003
- The U.S. Pharmacopeia Drug Utilization Review Advisory Panel, "Drug Utilization Review: Mechanisms to Improve Its Effectiveness and Broaden Its Scope", J Am Pharm Assoc, 40(4), pp.538~545 (2000)
- "약제정보 -처방조제안전정보"[URL]
- Forni A, "Technology utilization to prevent medication errors", Curr Drug Saf, 5(1), pp.13~18 (2010)
- David H. S, "The Impact of Prescribing Safety Alerts for Elderly Persons in an Electronic Medical Record", Arch Intern Med, 166, pp.1098~1104 (2006)
- Jean-Pierre G, "Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study", BMC Health Medical Research, 6, pp.1~11 (2006)